Skip to main content
Clinical Trials/CTRI/2023/05/052885
CTRI/2023/05/052885
Completed
未知

A randomized, double-blinded, controlled study to evaluate the efficacy of test products in providing skin moisturization and barrier protection for up to 24 hours in healthy subjects.

Sami-Sabinsa Group Ltd0 sites30 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sami-Sabinsa Group Ltd
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 1, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy female subjects, as determined from a recent medical history.
  • 2\. Subjects in the age group of 18\-45 years (both ages inclusive).
  • 3\. Subjects who present normal to dry skin on the forearm (corneometer value of
  • 35 as maximum)
  • 4\. Healthy skin in the test sites.
  • 5\. Subjects willing to give voluntary written informed consent and agree to come
  • for regular follow\-up.
  • 6\. Subjects willing to abide by and comply with the study protocol.
  • 7\. Subjects who are willing not to participate in any other clinical study during participation in the current study.

Exclusion Criteria

  • 1\. Excessive hair on the test site
  • 2\. A known history or present condition of an allergic response to any cosmetic
  • 3\. Change personal nutrition habits as well as sports habits
  • 4\. Start or change their oral hormonal treatment or their oral contraception.
  • 5\. Subject having active skin diseases (e.g., active atopic dermatitis, pigmented
  • contact dermatitis or other cutaneous manifestations), which will interfere with
  • the assessment.
  • 6\. Subjects on oral medications (e.g. steroids, anti\-oxidant) which will
  • compromise the study.
  • 7\. Subjects had cancer in the last 10 years

Outcomes

Primary Outcomes

Not specified

Similar Trials